Clinical Trial: Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy
Study Status: Completed
Recruit Status: RECRUITING
Condition: Diffuse Large B Cell Lymphoma
Study Type: INTERVENTIONAL
Official Title: A Phase 2, Single-Arm, Open-Label Study Using Itacitinib as Pre-Modulation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Receiving CAR-T-Cell Therapy
Brief Summary:
The purpose of the study is to assess the safety and efficacy of once daily itacitinib oral administration in participants with diffuse large B-cell lymphoma (DLBCL) who will receive CAR-T cell therapy with axicabtagene ciloleucel (axi-cel).
Read more